Stomach bugs: What’s new in 2024
Many open questions remain about the microbes in the stomach, an environment long considered inhospitable. Our understanding of the gastric environment has been revolutionized over the last four decades by the identification of Helicobacter pylori (H. pylori). Despite significant advances, we are st...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Verduci Editore
2024-10-01
|
| Series: | Microbiota in Health and Disease |
| Subjects: | |
| Online Access: | https://www.microbiotajournal.com/wp-content/uploads/sites/7/2024/09/e1104.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841560923526922240 |
|---|---|
| author | K. Lehr C. Thon M. Ebert A. Link |
| author_facet | K. Lehr C. Thon M. Ebert A. Link |
| author_sort | K. Lehr |
| collection | DOAJ |
| description | Many open questions remain about the microbes in the stomach, an environment long considered inhospitable. Our understanding of the gastric environment has been revolutionized over the last four decades by the identification of Helicobacter pylori (H. pylori). Despite significant advances, we are still unraveling the complex interactions within this ecosystem and identifying new microbial players in the acidic environment. In this review, we summarize the annual knowledge on the gastric microbiota published from 2023 to 2024, providing a comprehensive overview of the latest findings. Recent data shed light on the dynamics of the microbiome in the healthy state, as well as after H. pylori eradication and antibiotic resistance. Research on the microbiome in gastric cancer is revealing information about microbiota transitions during cancer progression and the potential role of the microbiome in assessing disease phenotype. The evidence surrounding Fusobacterium nucleatum (F. nucleatum) provides strong support for its clinical impact, although other bacteria and viruses also contribute. We look forward to further developments in this area, particularly in translating knowledge into clinical practice to improve the diagnosis and treatment of gastric diseases. |
| format | Article |
| id | doaj-art-ca6f073dc1c549fcb3044af63b8e7222 |
| institution | Kabale University |
| issn | 2704-8845 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Verduci Editore |
| record_format | Article |
| series | Microbiota in Health and Disease |
| spelling | doaj-art-ca6f073dc1c549fcb3044af63b8e72222025-01-03T10:30:12ZengVerduci EditoreMicrobiota in Health and Disease2704-88452024-10-01610.26355/mhd_202410_11041104Stomach bugs: What’s new in 2024K. Lehr0C. Thon1M. Ebert2A. Link3Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, GermanyDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, GermanyDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, GermanyDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, GermanyMany open questions remain about the microbes in the stomach, an environment long considered inhospitable. Our understanding of the gastric environment has been revolutionized over the last four decades by the identification of Helicobacter pylori (H. pylori). Despite significant advances, we are still unraveling the complex interactions within this ecosystem and identifying new microbial players in the acidic environment. In this review, we summarize the annual knowledge on the gastric microbiota published from 2023 to 2024, providing a comprehensive overview of the latest findings. Recent data shed light on the dynamics of the microbiome in the healthy state, as well as after H. pylori eradication and antibiotic resistance. Research on the microbiome in gastric cancer is revealing information about microbiota transitions during cancer progression and the potential role of the microbiome in assessing disease phenotype. The evidence surrounding Fusobacterium nucleatum (F. nucleatum) provides strong support for its clinical impact, although other bacteria and viruses also contribute. We look forward to further developments in this area, particularly in translating knowledge into clinical practice to improve the diagnosis and treatment of gastric diseases.https://www.microbiotajournal.com/wp-content/uploads/sites/7/2024/09/e1104.pdfhelicobacter pylorigastric microbiotastomachgastric cancerprognosis. |
| spellingShingle | K. Lehr C. Thon M. Ebert A. Link Stomach bugs: What’s new in 2024 Microbiota in Health and Disease helicobacter pylori gastric microbiota stomach gastric cancer prognosis. |
| title | Stomach bugs: What’s new in 2024 |
| title_full | Stomach bugs: What’s new in 2024 |
| title_fullStr | Stomach bugs: What’s new in 2024 |
| title_full_unstemmed | Stomach bugs: What’s new in 2024 |
| title_short | Stomach bugs: What’s new in 2024 |
| title_sort | stomach bugs what s new in 2024 |
| topic | helicobacter pylori gastric microbiota stomach gastric cancer prognosis. |
| url | https://www.microbiotajournal.com/wp-content/uploads/sites/7/2024/09/e1104.pdf |
| work_keys_str_mv | AT klehr stomachbugswhatsnewin2024 AT cthon stomachbugswhatsnewin2024 AT mebert stomachbugswhatsnewin2024 AT alink stomachbugswhatsnewin2024 |